Physician profile
Khubaib Mapara
NPI 1912101403
$2,383.73
in general payments reported to CMS, 2019-2025
8 companies · $958 in 2025
The $958 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2023: $158 · 2024: $452 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017 · Education: $311 · Travel and Lodging: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.94 |
| Education | $310.82 |
| Travel and Lodging | $240.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $674.04 | 2019 | |
| W. L. Gore & Associates, INC. | $554.63 | 2024-2025 | Gore Viabahn Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $398.63 | 2023-2024 | Endurant Iis, Venaseal |
| Cook Medical LLC | $348.48 | 2025 | Zenith Spiral-Z |
| Boston Scientific Corporation | $148.69 | 2025 | Enroute Transcarotid Neuroprotection System |
| Bolton Medical INC | $141.69 | 2019 | |
| Penumbra, INC. | $102.90 | 2024 | Indigo System |
| Integra Lifesciences Corporation | $14.67 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khubaib Mapara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.